mesalamine has been researched along with Pulmonary Fibrosis in 7 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Pulmonary Fibrosis: A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pulmonary fibrosis is one of the most important pathological processes associated with paraquat (PQ) poisoning." | 8.12 | 5‑Aminosalicylic acid attenuates paraquat‑induced lung fibroblast activation and pulmonary fibrosis of rats. ( Chen, H; Cui, J; Gong, Y; Liu, L; Ma, Y; Tian, Y; Tong, F; Wang, J; Wang, Y; Zhang, X, 2022) |
| "Pulmonary fibrosis is one of the most important pathological processes associated with paraquat (PQ) poisoning." | 4.12 | 5‑Aminosalicylic acid attenuates paraquat‑induced lung fibroblast activation and pulmonary fibrosis of rats. ( Chen, H; Cui, J; Gong, Y; Liu, L; Ma, Y; Tian, Y; Tong, F; Wang, J; Wang, Y; Zhang, X, 2022) |
| "She had past history of ulcerative colitis with the continued medication of mesalazine without success." | 1.36 | Combinational effect of low-dose oral corticosteroid and mizoribine for ulcerative colitis in a patient with systemic sclerosis. ( Ohtsuka, T, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H | 1 |
| Cui, J | 1 |
| Wang, J | 1 |
| Wang, Y | 1 |
| Tong, F | 1 |
| Tian, Y | 1 |
| Gong, Y | 1 |
| Ma, Y | 1 |
| Liu, L | 1 |
| Zhang, X | 1 |
| Alskaf, E | 1 |
| Aljoudeh, A | 1 |
| Edenborough, F | 1 |
| Ohtsuka, T | 1 |
| Pérez de Llano, LA | 1 |
| Lancho, A | 1 |
| Soilán del Cerro, JL | 1 |
| López-Róses, L | 1 |
| Lázaro, MT | 1 |
| García-Tejero, MT | 1 |
| Díaz-Lobato, S | 1 |
| Hesselmann, J | 1 |
| Kuhn, M | 1 |
| Ostendorf, PC | 1 |
| Huep, WW | 1 |
| Sullivan, SN | 1 |
7 other studies available for mesalamine and Pulmonary Fibrosis
| Article | Year |
|---|---|
5‑Aminosalicylic acid attenuates paraquat‑induced lung fibroblast activation and pulmonary fibrosis of rats.
Topics: Acute Lung Injury; Animals; Disease Models, Animal; Fibroblasts; Humans; Lung; Male; Mesalamine; Par | 2022 |
Mesalazine-induced lung fibrosis.
Topics: Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Humans; Male; Mesalamine; | 2013 |
Combinational effect of low-dose oral corticosteroid and mizoribine for ulcerative colitis in a patient with systemic sclerosis.
Topics: Adrenal Cortex Hormones; Antibodies, Antinuclear; Colitis, Ulcerative; Drug Therapy, Combination; Es | 2010 |
Cryptogenic fibrosing alveolitis predating ulcerative colitis.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprin | 1996 |
Mesalamine-induced lung disease.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Humans; Male; Me | 1997 |
[Acute alveolitis in ulcerative colitis: extra-intestinal organ complication or drug side effect].
Topics: Adult; Aminosalicylic Acids; Bronchoalveolar Lavage Fluid; Colitis, Ulcerative; Diagnosis, Different | 1991 |
Sulfasalazine lung. Desensitization to sulfasalazine and treatment with acrylic coated 5-ASA and azodisalicylate.
Topics: Adult; Aminosalicylic Acids; Bronchiolitis Obliterans; Colitis, Ulcerative; Desensitization, Immunol | 1987 |